Fanconi anemia (FA) is an inherited disorder of genomic instability associated with high risk of myelodysplasia and AML. Young mice deficient in FA core complex genes do not naturally develop cancer, hampering preclinical studies on malignant hematopoiesis in FA. Here we show that aging Fancc−/− mice are prone to genomically unstable AML and other hematologic neoplasms. We demonstrate that aneuploidy precedes malignant transformation during Fancc−/− hematopoiesis. Our observations reveal that Fancc−/− mice develop hematopoietic chromosomal instability followed by leukemia in age-dependent manner, recapitulating the clinical phenotype of human Fanconi anemia and providing a proof of concept for future development of preclinical models of FA-associated leukemogenesis.
INTRODUCTION
The Fanconi anemia (FA) signaling network protects genomic integrity and prevents cancer by facilitating interphase DNA repair and orchestrating cell division [1] [2] [3] . Germline biallelic mutations of any FA genes cause Fanconi anemia (FA), an inherited bone marrow failure syndrome associated with myelodysplasia (MDS) and acute myeloid leukemia (AML). The overall risk of leukemia in FA is increased 600-fold 4 .
Young mice deficient in core FA genes do not spontaneously recapitulate clinical hematopoietic manifestations of Fanconi anemia 5 . Fancc−/− mice demonstrate hypersensitivity to cross-linking agents 6 , decreased hematopoietic stem cell repopulating ability 7, 8 , and hypersensitivity to interferon-gamma 8 reflecting disruption of the FA signaling network during hematopoiesis. However, young Fancc−/− mice do not develop spontaneous leukemia or bone marrow failure 6, 8 . One observation study of a small Fancc−/− mouse cohort (n=8) did not detect decreased survival 9 . However, FA patients very rarely develop AML in their first year of life 10 and two soft-tissue tumors (adenocarcinoma and histiocytic sarcoma) had been reported in >13-month old Fancc−/− mice 11 . Thus, we hypothesized that aging Fancc−/− mice may be predisposed to hematopoietic malignancies.
If the absolute time to the onset of leukemia is similar in FA humans and mice, a long-term observation of FA−/− mice may be crucial to detect cancer predisposition. To address this translationally relevant question, we asked whether Fancc−/− mice develop malignancies as they age.
RESULTS & DISCUSSION
We observed cohorts of wt (n=20) and Fancc−/− (n=18) mice for 24 months, and noticed decreased survival of Fancc−/− mice (p=0.01, Fig. 1A ). Five Fancc−/− mice (27.8%) died between 8 and 24 months of age due to leukemia or lymphoma (Fig. 1B-L) . Specifically, we diagnosed acute myeloid leukemia (AML) in two moribund Fancc−/− mice with peripheral blasts, predominance of Gr-1+ (Ly-6G) peripheral blood low-density mononuclear cells (LDMNCs), and myeloid infiltrates around the liver vessels ( Fig. 1C-E) . One Fancc−/− mouse developed lethal B-cell acute lymphoblastic leukemia (ALL), as evidenced by expansion of B220+ blasts that replaced >90% of bone marrow and infiltrated the liver (Fig.  1F-H) . Additionally, two Fancc−/− mice died due to metastatic abdominal T-cell lymphoma manifested by massive mesenteric lymph node conglomerates ( Fig. 1I-J) accompanied by Cd3+ liver infiltrates (Fig. 1K-L) in the absence of bone marrow or peripheral blood abnormalities. After 24 months of observation, all surviving Fancc−/− and wt mice were sacrificed and examined by necropsy. 4/13 (30.8%) 2-year old Fancc−/− animals had hematopoietic solid tumors and/or peripheral blasts, consistent with leukemia/lymphoma. Serial blood counts did not reveal progressive pancytopenia in aging Fancc−/− mice, suggesting that the development of leukemia may not be preceded by bone marrow failure in this animal model of FA. Together, 9/18 Fancc−/− mice developed hematopoietic malignancies by two years of age (including 5 animals that died prematurely due to disease), compared to 0/20 control wt mice (Fig. 1B, p=0 .0003). Thus, aging Fancc−/− mice are prone to hematopoietic neoplasms, reflecting the age-dependent risk of leukemia in FA patients 4, 10, 12 .
We next asked whether Fancc−/− AML can be propagated in wt mice via competitive stem cell transplantation. We mixed donor Fancc−/− Cd45.2+ LDMNCs isolated from a moribund AML Fancc−/− mouse ( Fig. 1C-E ) with wt Cd45.1+ competitor LDMNCs at a 1:1 ratio and transplanted the mixed cells into 3 lethally irradiated wt recipients. Three wt recipients of age-matched wt Cd45.2+ LDMNCs mixed with wt Cd45.1+ LDMNCs served as controls ( Fig. 2A) . By 50 days post-transplantation, all recipients of Fancc−/− LDMNCs had died of AML, while control recipients of wt LDMNCs remained healthy (Fig. 2B) . The diagnosis of AML was confirmed in all recipients by flow cytometry, peripheral blood smears (Fig. 2C) and splenomegaly (p=0.0216, Fig. 2D) . Peripheral blood flow cytometry demonstrated increased Cd45.2+ chimerism (p=0.0436) in recipients of leukemic Fancc−/− LDMNCs compared to controls at one month post-transplant (Fig. 2E-F) , highlighting the malignant potential of leukemic Fancc−/− LDMNCs to outcompete wt hematopoietic cells in the host marrow.
The FA signaling network maintains genomic integrity during Fancc−/− hematopoiesis in vivo 13 and genomic instability promotes cancer 14 . Thus, we asked whether leukemic Fancc −/− mice displayed increased chromosomal instability and whether chromosomal instability precedes the onset of leukemia during Fancc−/− hematopoiesis. We compared karyotypes of LDMNCs isolated from leukemic Fancc−/− to age-matched wt and healthy Fancc−/− marrows. Bone marrow cells isolated from healthy Fancc−/− mice had higher incidence of aneuploidy and increased frequency of abnormal mitotic figures than wt LDMNCs (Fig. 3A-D) , showing that Fancc−/− hematopoietic cells become chromosomally unstable before overt leukemogenesis occurs. Similarly, FA patients develop hematopoietic chromosomal and nuclear abnormalities prior to the onset of leukemia 13, 15, 16 . Leukemic Fancc−/− bone marrows were more aneuploid (Fig. 3B) with higher mitotic index compared to both agematched wt (p=0.001) and Fancc−/− non-leukemic marrows (p<0.0001, Fig. 3D ). This observation is consistent with further exacerbation of genomic instability and acquisition of bizarre karyotypic abnormalities reported in human FA-associated AML 17, 18 .
In summary, Fancc−/− mice develop chromosomally unstable hematopoietic malignancies as they age, recapitulating clinical and genomic abnormalities seen in Fanconi anemia patients (Figs. 1 and 3) . Interestingly, similar incidence of tumors had been reported in old mice deficient in another FA core gene, Fanca, although that observation did not reach statistical significance due to small sample sizes 19 . Thus, late-onset carcinogenesis may be a common phenotype of murine FA core gene knockouts. AML arising in Fancc−/− mice can be propagated via hematopoietic stem cell transplant and produce rapid onset of lethal leukemia in wt transplant recipients (Fig. 2) . As large-scale cohorts of leukemic mice are essential for preclinical drug testing, our observations may facilitate the development of future preclinical models of FA−/− AML.
METHODS

Mice
C57Bl/6J Fancc−/− mice were a gift of David W. Clapp (Indiana University). Mice were PCR-genotyped as described 9 . B6.SJL-Ptprc a Pepc b /BoyJ mice were purchased from the IU In Vivo Therapeutics Core. All studies were approved by the Institutional Animal Care and Use Committee at IU.
Marrow harvest and transplantation
Bone marrow cells were flushed from mouse femurs using a 23-gauge needle/syringe (Becton Dickinson). LDMNCs were isolated by density gradient using Histopaque-1119 (Sigma) centrifuging for 30 minutes at 1800rpm with no brake. After centrifugation, LDMNCs were removed from the interface and utilized for experiments. Cytospins were made by resuspending LDMNCs in PBS and centrifuging onto slides at 450rpm for 5 minutes on a Shandon Cytospin 3 Cytocentrifuge (Thermo Scientific). 1.5×10 6 donor test LDMNCs (C57Bl/6J background) and 1.5×10 6 donor competitor BoyJ LDMNCs were transplanted into recipients via tail vein injection. Recipients were 8 week-old female B6.SJL-Ptprc a Pepc b /BoyJ mice that underwent whole-body split-dose 1100 rads irradiation (700 rads/400 rads, 4 hours apart). For chimerism analysis, peripheral blood was collected from lateral tail veins into EDTA-coated tubes, incubated with RBC lysis solution (Qiagen) for 10 minutes at room temperature, washed, stained with anti-Cd45.2-FITC (BD Biosciences) and anti-Cd45.1-PE (BD Biosciences) as described 9 , and analyzed on a FacsCalibur machine (Becton-Dickinson). At least 10,000 events/sample were acquired and analyzed using FlowJo Software.
Metaphase spreads
Bone marrow cells flushed from tibias were cultured in IMDM plus 20% FBS, murine SCF (100ng/ml), and IL-6 (200ng/ml) for 2 days. Cells were then exposed to 0.2 μg/ml colcemid (Life Tech) for 4 hours and pelleted at 800rpm for 5 minutes. Cells were resuspended dropwise in pre-warmed (37°C) 75mM KCl, and incubated at 37°C for 15 minutes. After pelleting, cells were resuspended in a 3:1 methanol:glacial acetic acid fixative. Cells were pelleted and resuspended in fixative two additional times before being dropped onto slides and dried overnight. Spreads were stained with Vectashield mounting medium with DAPI (Vector Laboratories).
Histology and flow cytometry
Murine tissues obtained post-mortem were fixed in 10% formalin, paraffin-embedded, sectioned (5 μM sections), and stained with hematoxylin and eosin. Peripheral blood smears and bone marrow cytospins were stained with Giemsa using the automated Siemens Hematek 3000 (Fisher) system. For flow cytometry, peripheral blood cells were incubated in RBC lysis solution and bone marrow LDMNCS were isolated as described above. Cells were stained with either Gr-1-APC (Ly6G, clone: RB6-8C5) or B220-FITC (clone: RA3-6B2), analyzed on a FacsCalibur machine using live gating followed by data quantification with FlowJo software. Leukemia diagnoses were made using criteria established in the Bethesda proposal for classification of nonlymphoid neoplasms in mice 20 , and were independently validated by a veterinary pathologist at IU School of Medicine.
Microscopy
Images of smears, cytospins, and histological sections were obtained using a Zeiss Axiolab microscope with a color camera. Metaphase spreads were imaged on a Deltavision personalDx deconvolution microscope (Applied Precision). Image stacks (distance between z-sections: 0.2 μm) were deconvolved using Softworx and analyzed using Imaris software suite (Bitplane). 
